Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Progression patterns in patien...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Progression patterns in patients with advanced hepatocellular carcinoma treated with local therapy, targeted drugs, and PD-1/PD-L1 inhibitors

Progression patterns in patients with advanced hepatocellular carcinoma treated with local therapy, targeted drugs, and PD-1/PD-L1 inhibitors

Bibliographic Details
Main Authors: Yanan Zhao, Di Wu, Quanjun Yao, Hang Yuan, Hongtao Hu, Hailiang Li
Format: Article
Language:English
Published: Termedia Publishing House 2024-08-01
Series:Central European Journal of Immunology
Subjects:
hepatocellular carcinoma
disease progression
local therapy
targeted drug
pd-1/pd-l1 inhibitor
Online Access:https://www.termedia.pl/Progression-patterns-in-patients-with-advanced-hepatocellular-carcinoma-treated-with-local-therapy-targeted-drugs-and-PD-1-PD-L1-inhibitors,10,54650,1,1.html
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

https://www.termedia.pl/Progression-patterns-in-patients-with-advanced-hepatocellular-carcinoma-treated-with-local-therapy-targeted-drugs-and-PD-1-PD-L1-inhibitors,10,54650,1,1.html

Similar Items

  • PD-1/PD-L1 checkpoint inhibitors in advanced hepatocellular carcinoma immunotherapy
    by: Qian Li, et al.
    Published: (2022-12-01)
  • Research Progress on Cardiotoxicity of PD-1/PD-L1 Immune Checkpoint Inhibitors
    by: YU Lin, et al.
    Published: (2021-08-01)
  • Hepatocellular Carcinoma with Radiological Progression: Lenvatinib Plus PD-1 Inhibitor Combined with Microwave Ablation and Synchronous Transarterial Chemoembolization
    by: Shi Q, et al.
    Published: (2023-10-01)
  • PD-1 inhibitors plus lenvatinib versus PD-1 inhibitors plus regorafenib in patients with advanced hepatocellular carcinoma after failure of sorafenib
    by: Yongkang Xu, et al.
    Published: (2022-09-01)
  • A FAK Inhibitor Boosts Anti-PD1 Immunotherapy in a Hepatocellular Carcinoma Mouse Model
    by: Yuhua Wei, et al.
    Published: (2022-01-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs